Answers are grounded in this paper and cite their sources.
Research reveals chronic myelinopathy in the pontine region mediates blast-mTBI symptoms, indicating potential therapies.
Diffuse mild traumatic brain injury (mTBI) often leads to persistent post-concussive symptoms (PCS) such as fragmented sleep, yet the brain loci and cellular mechanisms that link injury to disability remain obscure. We tested the hypothesis that repeated blast-induced mTBI provokes a chronic myelinopathy with accompanied microglial response in the pontine reticular formation, a brainstem region that modulates arousal and sleep, and that this pathology statistically mediates persistent PCS burden. Using spatially resolved single cell phenotyping in a mouse model of blast-mTBI, we found that only repeated mTBI established persistent activation of disease-associated microglia and phagocytosis of myelin in the pontine reticular formation. Parallel studies in veterans with repeated blast-mTBI revealed identical microglial nodules on neuropathological exam up to two decades after documented blast injury, while diffusion tensor imaging confirmed a dose-dependent pontine myelin disruption that statistically mediated sleep disturbance and broad PCS. Together, these data identify pontine white matter pathology as both a biomarker and mechanistic driver of chronic PCS after repeated diffuse mTBI, highlighting brainstem microglia and oligodendrocytes as rational therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Meabon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: